Share
- Release Date: 01/02/13 15:24
- Summary: RELINT: ABA: Ongoing Disclosure Notice - D.Chan
- Price Sensitive: No
- Download Document 1.86KB
ABA
01/02/2013 13:23
RELINT
REL: 1323 HRS Abano Healthcare Group Limited
RELINT: ABA: Ongoing Disclosure Notice - D.Chan
Ongoing Disclosure Notice
Disclosure of Directors and Officers Relevant Interests
Section 19T(2), Securities Markets Act 1988
A Details of director or officer
Name of director or officer of public issuer: Danny Chan
Name of public issuer: Abano Healthcare Group Limited
Name of related body corporate (if applicable): N/A
Position held in public issuer: Director
B Securities in public issuer or related body corporate to which this
disclosure relates
Number, class, and type of securities: 15 ordinary shares
C Nature of relevant interest and name of registered holder
Nature of relevant interest in those securities: Registered holder &
beneficial owner
Name of registered holder of those securities Danny Chan
D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition: 29 January 2013
Consideration paid for acquisition: $6.41 per share
If the relevant interest was disposed of--
Date of disposal: N/A
Consideration received for disposal: N/A
Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acquisition or disposal took place: Issue of shares pursuant to
participation in the Dividend Reinvestment Plan for the 2013 interim dividend
E Total number of transactions this notice relates to: 1 transaction
F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer: 14 November 2012
G Signature
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature: 1 February 2013
Name and title of authorised person: "Richard Keys
Chief Operating Officer / Chief Financial Officer"
End CA:00232542 For:ABA Type:RELINT Time:2013-02-01 13:24:00
